Abstract 5566: LYC-55716, a first-in-class RORγ agonist: Rationale and preclinical data to support clinical combinations with established immunotherapies

Name: Work Video:
Duration: 3 min 30 s
Xiao Hu; Xikui Liu; Hongxiu Li; Garry Weems; Elizabeth M. Zawidzka; Yilin Gao; H. Jeffrey Wilkins; Laura Carter
{'id': 'https://openalex.org/W2887151306', 'doi': 'https://doi.org/10.1158/1538-7445.am2018-5566', 'title': 'Abstract 5566: LYC-55716, a first-in-class RORγ agonist: Rationale and preclinical data to support clinical combinations with established immunotherapies', 'display_name': 'Abstract 5566: LYC-55716, a first-in-class RORγ agonist: Rationale and preclinical data to support clinical combinations with established immunotherapies', 'publication_year': 2018, 'publication_date': '2018-07-01', 'ids': {'openalex': 'https://openalex.org/W2887151306', 'doi': 'https://doi.org/10.1158/1538-7445.am2018-5566', 'mag': '2887151306'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2018-5566', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5008596951', 'display_name': 'Xiao Hu', 'orcid': 'https://orcid.org/0000-0002-3737-7958'}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xiao Hu', 'raw_affiliation_strings': ['1Lycera Corp., Ann Arbor, MI;'], 'affiliations': [{'raw_affiliation_string': '1Lycera Corp., Ann Arbor, MI;', 'institution_ids': ['https://openalex.org/I4210145030']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101488371', 'display_name': 'Xikui Liu', 'orcid': 'https://orcid.org/0000-0002-4509-9468'}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xikui Liu', 'raw_affiliation_strings': ['1Lycera Corp., Ann Arbor, MI;'], 'affiliations': [{'raw_affiliation_string': '1Lycera Corp., Ann Arbor, MI;', 'institution_ids': ['https://openalex.org/I4210145030']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075700357', 'display_name': 'Hongxiu Li', 'orcid': 'https://orcid.org/0000-0002-7447-1222'}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hongxiu Li', 'raw_affiliation_strings': ['1Lycera Corp., Ann Arbor, MI;'], 'affiliations': [{'raw_affiliation_string': '1Lycera Corp., Ann Arbor, MI;', 'institution_ids': ['https://openalex.org/I4210145030']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015407851', 'display_name': 'Garry Weems', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Garry Weems', 'raw_affiliation_strings': ['2Lycera Corp., Plymouth Meeting, PA.'], 'affiliations': [{'raw_affiliation_string': '2Lycera Corp., Plymouth Meeting, PA.', 'institution_ids': ['https://openalex.org/I4210145030']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5068912199', 'display_name': 'Elizabeth M. Zawidzka', 'orcid': 'https://orcid.org/0000-0003-1647-8466'}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elizabeth Zawidzka', 'raw_affiliation_strings': ['1Lycera Corp., Ann Arbor, MI;'], 'affiliations': [{'raw_affiliation_string': '1Lycera Corp., Ann Arbor, MI;', 'institution_ids': ['https://openalex.org/I4210145030']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101781557', 'display_name': 'Yilin Gao', 'orcid': 'https://orcid.org/0000-0001-7964-4260'}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yilin Gao', 'raw_affiliation_strings': ['1Lycera Corp., Ann Arbor, MI;'], 'affiliations': [{'raw_affiliation_string': '1Lycera Corp., Ann Arbor, MI;', 'institution_ids': ['https://openalex.org/I4210145030']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103921226', 'display_name': 'H. Jeffrey Wilkins', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'H. Jeffrey Wilkins', 'raw_affiliation_strings': ['2Lycera Corp., Plymouth Meeting, PA.'], 'affiliations': [{'raw_affiliation_string': '2Lycera Corp., Plymouth Meeting, PA.', 'institution_ids': ['https://openalex.org/I4210145030']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5040898659', 'display_name': 'Laura Carter', 'orcid': 'https://orcid.org/0000-0003-3589-6225'}, 'institutions': [{'id': 'https://openalex.org/I4210145030', 'display_name': 'Lycera (United States)', 'ror': 'https://ror.org/04k8pqm06', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210145030']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Laura Carter', 'raw_affiliation_strings': ['1Lycera Corp., Ann Arbor, MI;'], 'affiliations': [{'raw_affiliation_string': '1Lycera Corp., Ann Arbor, MI;', 'institution_ids': ['https://openalex.org/I4210145030']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.105, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.576023, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 70, 'max': 74}, 'biblio': {'volume': '78', 'issue': '13_Supplement', 'first_page': '5566', 'last_page': '5566'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11313', 'display_name': 'Immune cells in cancer', 'score': 0.9787, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9694, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/orphan-receptor', 'display_name': 'Orphan receptor', 'score': 0.51569825}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6189278}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.55131495}, {'id': 'https://openalex.org/C2778938600', 'wikidata': 'https://www.wikidata.org/wiki/Q389934', 'display_name': 'Agonist', 'level': 3, 'score': 0.5248449}, {'id': 'https://openalex.org/C2779161069', 'wikidata': 'https://www.wikidata.org/wiki/Q2496179', 'display_name': 'Orphan receptor', 'level': 4, 'score': 0.51569825}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5119642}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4881316}, {'id': 'https://openalex.org/C74737994', 'wikidata': 'https://www.wikidata.org/wiki/Q18031207', 'display_name': 'RAR-related orphan receptor gamma', 'level': 4, 'score': 0.47406667}, {'id': 'https://openalex.org/C2781121885', 'wikidata': 'https://www.wikidata.org/wiki/Q425517', 'display_name': 'Retinoic acid', 'level': 3, 'score': 0.44059056}, {'id': 'https://openalex.org/C154317977', 'wikidata': 'https://www.wikidata.org/wiki/Q376266', 'display_name': 'Cytotoxic T cell', 'level': 3, 'score': 0.4142371}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.3234757}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.29796785}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.29614568}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.24408737}, {'id': 'https://openalex.org/C2779727006', 'wikidata': 'https://www.wikidata.org/wiki/Q426188', 'display_name': 'FOXP3', 'level': 3, 'score': 0.23144251}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.2191532}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.1293405}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.12286097}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.06659138}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2018-5566', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.83, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4235654911', 'https://openalex.org/W3198715923', 'https://openalex.org/W3106615265', 'https://openalex.org/W2994939569', 'https://openalex.org/W2948710961', 'https://openalex.org/W2908928650', 'https://openalex.org/W2368424105', 'https://openalex.org/W2350475825', 'https://openalex.org/W2034599968', 'https://openalex.org/W126646489'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1], 'retinoic': [2], 'acid-related': [3], 'orphan': [4], 'receptor': [5, 11], 'γt': [6], '(RORγt)': [7], 'is': [8], 'a': [9, 88, 217, 231, 245, 312], 'nuclear': [10], 'transcription': [12], 'factor': [13], 'that': [14, 39, 140, 147], 'acts': [15], 'as': [16, 114, 116], 'an': [17], 'immune': [18, 44, 51], 'cell': [19, 45, 258], 'master': [20], 'control': [21], 'switch': [22], 'driving': [23], 'the': [24, 58, 71, 98, 134, 138, 162, 185, 207, 331], 'generation': [25], 'and': [26, 31, 53, 92, 119, 146, 202, 244, 317], 'function': [27], 'of': [28, 133, 184, 198, 235, 249, 262, 271, 330], 'Th17': [29], '(helper)': [30], 'Tc17': [32], '(cytotoxic)': [33], 'T': [34], 'cells.': [35], 'Preclinical': [36], 'data': [37, 86, 319], 'show': [38], 'synthetic': [40], 'RORγ': [41, 62, 99, 141, 153, 163, 188, 212, 314], 'agonists': [42, 63, 142], 'modulate': [43], 'gene': [46], 'expression': [47, 145], 'to': [48, 73, 78, 84, 103, 130, 194, 320], 'both': [49], 'increase': [50], 'activity': [52, 197], 'decrease': [54, 143], 'immunosuppressive': [55], 'mechanisms': [56], 'in': [57, 166, 182, 237, 254, 267], 'tumor': [59, 80, 179, 263], 'microenvironment.': [60], 'Because': [61], 'impact': [64], 'multiple': [65], 'antitumor': [66, 196], 'mechanisms,': [67], 'these': [68], 'compounds': [69], 'have': [70], 'potential': [72], 'combine': [74], 'with': [75, 161, 172, 223, 239, 252, 256, 324], 'other': [76, 111, 224], 'agents': [77, 113, 158], 'enhance': [79], 'immunity.': [81], 'In': [82, 200], 'addition': [83], 'preclinical': [85, 201, 318], 'supporting': [87, 221], 'biologic': [89], 'rationale,': [90], 'bioinformatic': [91], 'machine': [93], 'learning': [94], 'approaches': [95], 'based': [96], 'on': [97, 137], 'pathway': [100], 'were': [101, 128, 159], 'undertaken': [102], 'prioritize': [104], 'possible': [105], 'clinical': [106, 205, 228, 322], 'combinations.': [107], 'This': [108], 'work': [109], 'highlighted': [110], 'immuno-oncology': [112, 225], 'well': [115], 'targeted': [117], 'therapies': [118], 'more': [120], 'conventional': [121], 'treatments.': [122], 'Preclinical,': [123], 'syngeneic': [124, 168, 268], 'mouse': [125], 'cancer': [126], 'models': [127, 186, 270], 'used': [129], 'test': [131], 'some': [132], 'hypotheses.': [135], 'Based': [136], 'finding': [139], 'PD-1': [144], 'anti-CTLA4': [148, 157], 'induces': [149], 'ICOS,': [150], 'which': [151], 'stabilizes': [152], 'expression,': [154], 'anti-PD1': [155], 'or': [156], 'combined': [160, 251], 'agonist': [164, 189, 213, 276, 278, 281], 'LYC-54143': [165], '12': [167], 'murine': [169, 269], 'models.': [170], 'Compared': [171], 'individual': [173], 'agents,': [174], 'combination': [175, 222], 'treatments': [176], 'elicited': [177], 'superior': [178], 'growth': [180, 264], 'inhibition': [181, 265], '6': [183], '(Table).': [187], 'treatment': [190], 'was': [191], 'also': [192], 'able': [193], 'augment': [195], 'doxorubicin.': [199], 'phase': [203, 232, 246], '1': [204], 'testing,': [206], 'first-in-class,': [208], 'investigational': [209], 'oral': [210], 'small-molecule': [211], 'LYC-55716': [214, 236, 250], 'has': [215], 'demonstrated': [216], 'favorable': [218], 'safety': [219], 'profile': [220], 'agents.': [226], 'Ongoing': [227], 'trials': [229], 'include': [230], '2a': [233], 'trial': [234, 248], 'patients': [238, 255], 'select': [240], 'solid': [241], 'tumors': [242], '(NCT02929862)': [243], '1b': [247], 'pembrolizumab': [253], 'non-small': [257], 'lung': [259], 'cancer.': [260], 'Percentage': [261], 'induced': [266], 'cancer.Murine': [272], 'modelAnti-PD1': [273], 'aloneAnti-CTLA4': [274], 'aloneRORγ': [275, 277], '+': [279, 282], 'anti-PD1RORγ': [280], 'anti-CTLA4H22': [283], '(Liver)30-50%&amp;gt;50%*10-30%&amp;gt;50%*&amp;gt;50%*Pan02': [284], '(Pancreas)&amp;lt;10%10-30%&amp;lt;10%10-30%*10-30%*CT26': [285], '(Colon)10-30%&amp;lt;10%&amp;lt;10%&amp;lt;10%30-50%B16F10': [286], '(Melanoma)10-30%10%10-30%10-30%30-50%A230': [287], '(Lymphoma)&amp;lt;10%&amp;lt;10%10-30%30-50%10%Renca': [288], '(Renal)&amp;lt;10%10-30%30-50%*30-50%*30-50%*P&amp;lt;.05': [289], 'vs': [290], 'vehicle.': [291], 'Citation': [292], 'Format:': [293], 'Xiao': [294], 'Hu,': [295], 'Xikui': [296], 'Liu,': [297], 'Hongxiu': [298], 'Li,': [299], 'Garry': [300], 'Weems,': [301], 'Elizabeth': [302], 'Zawidzka,': [303], 'Yilin': [304], 'Gao,': [305], 'H.': [306], 'Jeffrey': [307], 'Wilkins,': [308], 'Laura': [309], 'Carter.': [310], 'LYC-55716,': [311], 'first-in-class': [313], 'agonist:': [315], 'Rationale': [316], 'support': [321], 'combinations': [323], 'established': [325], 'immunotherapies': [326], '[abstract].': [327], 'In:': [328], 'Proceedings': [329], 'American': [332], 'Association': [333], 'for': [334], 'Cancer': [335, 348], 'Research': [336], 'Annual': [337], 'Meeting': [338], '2018;': [339], '2018': [340], 'Apr': [341], '14-18;': [342], 'Chicago,': [343], 'IL.': [344], 'Philadelphia': [345], '(PA):': [346], 'AACR;': [347], 'Res': [349], '2018;78(13': [350], 'Suppl):Abstract': [351], 'nr': [352], '5566.': [353]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2887151306', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}], 'updated_date': '2024-12-12T01:21:50.371521', 'created_date': '2018-08-22'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
